As people grow older, their immune systems do not simply slow down, they often become locked into a simmering, ...

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...

This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

These sequences are extremely prone to mutations and rank among the most functionally important regions in the entire human ...

Thanks to a first-of-its-kind platform, we are starting to understand how the molecular engine responsible for transcription in mammals controls its speed. A team of researchers from The Rockefeller ...

mRNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional proteins in the body and induces therapeutic effects.

STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a biotechnology company focused on providing nucleic acid production ...